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Sympathetic  Block  for  Treating  Primary  Erythromelalgia
Department of Anesthesiology and Pain Medicine, Kyungpook National University of Hospital, Daegu, Korea
Yoo  Jin  Bang,  MD,  Jin  Seok  Yeo,  MD,  Si  Oh  Kim,  MD,  and  Young  Hoon  Park,  MD
Primary erythromelalgia is a rare condition that’s characterized by erythema, an increased skin temperature 
and burning pain in the extremities. The pain is often very severe, and treating erythromelalgia is frustrating 
and difficult. We report here on the case of a 12-year old girl with primary erythromelalgia in both lower 
extremities. The pain was refractory to medical treatment, but a bilateral sympathetic block with lidocaine and 
triamcinolone resulted in relief from the pain. Our experience with this disease demonstrates that sympathetic 
blocks are effective in improving the symptoms and they may be attempted on erythromelalgia patients who 
do not respond to other treatments, including medication and epidural blocks. (Korean  J  Pain  2010;  23: 
55-59)
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　　Erythromelalgia is a combination of three Greek words: 
erythros (redness), melos  (extremities) and  algos (pain). 
Erythromelalgia describes a very rare condition of severe 
burning pain, redness and elevation in the body temper-
ature in the extremities [1]. In most cases, the pain is not 
continuous, but rather it is recurrent and lasts for several 
hours when it occurs. It attacks the lower extremities (88%) 
more often than it does the upper extremities (26%), yet 
it can attack both the upper and lower extremities [1,2]. 
There are many types of treatment for erythromelalgia. 
There are oral treatments such as neuroleptic drugs and 
vasodilator. Some kind of drug can be administered by in-
travenous injection. Sympathetic ganglion block and epi-
dural block are effective invasive procedures to treat this 
condition [3-6]. Yet of the many reported treatments there 
seems to be no treatment with consistent effects for all 
patients, so many combinations of treatment are usually 
tested on a single patient.
　　We report here on a child patient who suffered from 
recurrent pain and we tried treating her with various drug 
therapies, but with no success. Her pain was satisfactorily 
controlled after performing a sympathetic ganglion block, 
so we explore and discuss the case in this report.
CASE  REPORT
　　A 12-year old child with the height of 127 cm and a 
weight of 25 kg was experiencing severe pain in both her 56 Korean J Pain Vol. 23, No. 1, 2010
Fig. 1. The patient's feet at the time of visiting pain clinic.
feet, as well as skin ulcers, redness, swelling and flashes 
o f  h e a t  w h e n  s h e  w a s  a d m i t t e d  i n t o  o u r  h o s p i t a l ' s  
Department of Dermatology (Fig. 1). At around the age 3 
she began experiencing symptoms of redness, heatness 
and pain in both feet. The symptoms were alleviated when 
her feet were put in cold water. But when she walked or 
when her feet were exposed to heat, her symptoms be-
c a m e  w o r s e  t h a n  b e f o r e .  H e r  s y m p t o m s  a g g r a v a t e d  4  
months previous to admission, and for 2 weeks prior hos-
pital admission, she had to immerse her feet in cold water 
for 10 minutes at every hour during the day. The pain was 
so severe that she could not sleep properly, and she had 
t o  im m e r s e h e r f ee t  in  c o l d  w a t e r se v e r a l t i m es  i n t h e 
night. Her feet became swollen with small wounds, so she 
used the traditional healing method of repetitively immers-
ing her feet in loess-water, but her symptoms had rapidly 
worsened. For the family's medical history, her mother, 
maternal aunt, maternal grandmother and maternal female 
c o u s i n  h a d  t h e  s a m e  d i s e a s e ,  s o  a  m a t r i l i n e a l  h e r e d i t y 
pattern could be seen. The Department of Dermatology 
suspected  the  patient  to  have  erythromelalgia  accom-
panied by cellulitis and contact dermatitis, so many tests 
and treatment were done. The blood test results showed 
a n  E S R  o f  7 3  m m / h r  a n d  a n  e l e v a t e d  p l a t e l e t  l e v e l  o f 
598,000/μl, an AST of 51 U/L and an ALT of 48 U/L. There 
w e r e  n o  o t h e r  s y m p t o m s  i n d i c a t i n g  s e c o n d a r y  
erythromelalgia. On day 1 of admission, cephalosporin 1 g 
twice a day was administered. To control the pain, NSAIDs 
w e r e  a d m i n i s t e r e d  b y  i n t r a m u s c u l a r  i n j e c t i o n  w h e n  
necessary. Aspirin 500 mg 3 times a day, acetaminophen 
300 mg 3 times a day, prednisolone 10 mg twice a day 
and gabapentin 100 mg 3 times a day were administered. 
On day 2 of admission, the patient's skin lesions seemed 
to improve, but the pain was still not alleviated. So on day 
3, amitriptyline 10 mg was orally administered before she 
slept. On day 4, fluoxetin was administered at 10 mg a 
day. Her pain was still not mitigated, but now her feet had 
to be immersed in cold water at a higher frequency of ev-
ery 30 minutes instead of every hour. On day 6, due to 
her continuous pain, she was referred to the Department 
of Pain. She complained of pain at level 5 on the visual 
analogue scale. The skin lesions on both feet were almost 
all cured, but the feet were still swollen and red. The feet 
were very cold when there was no pain but when there was 
pain we can feel heatness on her feet. The child could not 
wear shoes because of the pain. She began using a wheel-
chair  for  transportation  because  walking  worsened  the 
pain. To control the pain, a caudal epidural block was per-
formed with a 23 G needle and using 0.3% lidocain 7 ml 
and triamcinolone 10 mg. The procedure still did not alle-
viate the pain. But the patient's skin lesions on her feet 
were almost all cured, so her parents had her discharged 
for personal reasons. She still continued taking antihist-
amine, gabapentin and fluoxetin after leaving the hospital. 
Nine days after her discharge, she visited a pain clinic, 
where her VAS score was still at level 5. However, she im-
mersed her feet every 30 minute or a hour interval during 
the day and still immersed her feet in the night as well. 
So we decided to perform a sympathetic ganglion block on 
right L3. The patient was placed in the prone position. 
Under C-arm fluoroscope guidance, we injected lidocaine 
in skin 4 cm away from the L3 spinous process for local 
anesthesia and 25 G spinal needle was inserted until the 
anterolateral aspect of the L3 vertebral body was touched 
and then contrast media was injected. The contrast media 
diffused from L2 to L3, and then 1% lidocaine 6 cc and 
triamcinolone 10 mg were administered (Fig. 2). After the 
procedure, the patient's feet temperature went from 27
oC 
to 30
oC and her pain also increased, so her feet had to 
be immediately placed in water. When she visited the pain 
clinic one week later, her VAS score went down to level 3. 
In the night in every 2-3 hours, she woke up from the pain 
in her feet and had to immerse her feet in cold water for 
10 minutes. The patient visited the hospital on foot and 
she was able to attend school again after the sympathetic YJ Bang, et al / Sympathetic Block for Erythromelalgia 57
Fig. 2. Lateral view of X-ray show spreading of mixture over
L3 vertebral region in sympathetic ganglion block.
g a n g l i o n  b l o c k .  H o w e v e r ,  t h e  r e d - s w e l l i n g  i n  h e r  f e e t  
remained. So a sympathetic ganglion block was performed 
again on left L3 with 1% lidocaine 6 cc and triamcinolone 
10 mg. Even after the second sympathetic ganglion block, 
the child-patient's pain score was elevated level 4 on the 
VAS score. After one weeks of the procedure, her VAS 
score was still at level 3 but the frequency of pain was 
reduced. During the day, she had to immerse her feet in 
cold water every 2-3 hours a day. In the night, she woke 
up 2-3 times to immerse her feet. The feet's swelling, red-
ness and sensation of burning were reduced. Four weeks 
after the procedure, she had to put her feet in cold water 
every 2-3 hours in a day and one time in the night but 
each time her feet were put in cold water, her feet did not 
become red or become hot as they used to. It is thought 
that she continued to put her feet in cold water during the 
day as well as when waking up at night because she was 
accustom to the habit, and this habit had been formed for 
a long time.
DISCUSSION
　　Erythromelalgia is a rare disease that occurs in 3 out 
of every 5,000 patients who are referred to pain clinics 
[3]. Erythromelagia can be divided into the primary and 
secondary cases depending on the cause. Primary eryth-
romelalgia is common in middle-aged males. But third of 
the cases of the patients are under 30 years of age and 
it can occurs amongst children and adolescents [6]. The 
disease has an autosomal dominant inheritance pattern. 
Patients with this disease have mutations in the SCN9A 
gene, which encodes the voltage gated sodium channels 
and these are primarily expressed within the nociceptive 
dorsal root ganglia and sympathetic ganglia, so patients 
with erythromelalgia have a low threshold to pain stim-
ulation [7-9]. Secondary erythromelalgia can be accom-
panied by myeloproliferative disease such as polycythemia 
vera, essential thromocytosis, leukemia and autoimmune 
disease such as systemic lupus erythematosus and dia-
betes [3]. The average age of secondary erythromelalgia 
occurrence is 59, so secondary erythromelalgia in children 
or teenagers is rare. The prevalence rate of secondary er-
ythromelalgia between males to females is equal [6]. In the 
case presented here, there were no signs or symptoms of 
secondary  erythromelalgia.  On  examining  the  family's 
medical history and considering the child-patient's young 
age, her case was diagnosed as primary erythromelalgia. 
The symptoms and signs for erythromelalgia are as fol-
lows: localized redness, swelling, burning pain and an in-
creased skin temperature in either the upper or lower ex-
tremities on both the right and left. The disease is caused 
or worsened when weight is put on the attacked area or 
the area's temperature is raised. When the attacked area 
is exposed to the cold or it is elevated or given rest, the 
condition is alleviated [3,10]. The patient in our case had 
these signs and symptoms. With the repetitious immersing 
of her feet, she developed immersion foot and a secondary 
ulcer and infection, which caused her condition to rapidly 
worsen.
　　Davis et al. [11] performed a retrospective study on 87 
erythromelalgia patients to determine its natural course. 
Localized lesions broke out in 21.8% of the cases where 
the patient immersed the attacked area, infection occurred 
in 16.1% of the cases, ulcer in 12.6% and gangrene in 1.1% 
and the attacked area has to be severed in severe cases. 
Because the disease affects the patient's quality of life, 
50% of the patients cannot take long walks, 12.5% have 
to leave work, 3% have to use a wheelchair and 2.1% are 
bed-ridden. Around the time before our patient was ad-
mitted to the hospital, she had to immerse her feet in the 
middle of class. This affected her school studies, so she 
could not attend school for a while. She could not partic-
ipate in out-door activities with other children. So doctor 
must actively try to alleviate the patient's pain with various 58 Korean J Pain Vol. 23, No. 1, 2010
treatments in order for the patients to continue their nor-
mal life-activities.
　　There  is  still  no  treatment  that  has  shown  stand-
ardized effects. Because the disease is very rare, research 
has been d one on only a small number of patients and 
there are only theories as to the pathology because the 
proven pathology has not yet been brought to light. Cohen 
[3] advocated educating patients with this disease on the 
causes that worsen the symptoms so that the patients can 
avoid exasperating environments and on how to safely care 
for attacked area. Medical treatment includes aspirin, ga-
bapentin, serotonin reuptake inhibitor, amitriptyline, pros-
taglandin and calcium channel blocker. But in most cases, 
their efficacies have not been proven or they are only lim-
ited [3,9,10,12]. If symptoms are not alleviated with oral 
medication,  then venous  administration of  nitroprusside, 
lidocaine and prostaglandin has been reported to mitigate 
these patients' symptoms [10]. In our patient's case, taking 
aspirin, gabapentin, fluoxetin and amitriptyline did not re-
lieve the symptoms.
　　The  invasive  procedures  for  erythromelalgia  include 
e p i d u r a l  b l o c k ,  s y m p a t h e t i c  g a n g l i o n  b l o c k ,  s p i n a l  c o r d  
s t i m u l a t o r  i n s e r t i o n  a n d  b r a c h i a l  p l e x u s  b l o c k  [ 3 , 1 3 ] .  
D'Angelo et al. [6] reported improvement of the patient's 
condition after inserting a lumbar epidural catheter and 
injecting the patient with local anesthetics and opioid. In 
our patient's case, we used steroid when we performed a 
caudal epidural block and a sympathetic ganglion block. 
Because steroid has anti-inflammatory effect by blocking 
production and release of the inflammatory mediator and 
it has the electrophysiological effect of changing the neu-
romuscular junction and neuron conduction. Also the corti-
costeroid may exert an "anesthetic" like action by blocking 
nociceptive C-fiber conduction and this is independent of 
corticosteroid's anti-inflammatory properties [14]. The ef-
fect of steroid is proportional to the distance from where 
they are injected to the area of nerve lesions, and these 
nerve lesions in the case of genetic erythromelalgia are 
caused by the changes in the voltage gated sodium chan-
nels in the nociceptive dorsal root ganglion and the sym-
pathetic ganglia. So we injected steroids near the sym-
pathetic ganglia and the dorsal root ganglion in the area 
o f t h e l es i o ns  t o  s ee  t h e  r e su l t s . T h e e ff ec t s  o f sy m-
pathetic ganglion blocks have been reported to vary de-
pending on different authors. For an erythoromelalgia pa-
tient suffering from severe pain in the lower extremities, 
Seishima et al. [15] prescribed many oral medications and 
performed an epidural block, but the pain was not relieved. 
So they performed a sympathetic ganglion block. Herein-
after, the patient did not experience pain for 9 months. 
Shiga et al. [16] performed a thoracic sympathectomy on 
a erythromelalgia patient who suffered from severe pain 
in  both  hands  and  the  pain  was  relieved  immediately. 
Although a sympathetic block alleviates symptoms in some 
patients, in other cases it worsens their condition. In some 
reports, a sympathectomy has been suggested only in pa-
tients for whom a diagnostic sympathetic block was effec-
tive [17]. Other reports have presented cases where the 
patient's symptoms worsened after receiving a unilateral 
sympathectomy. This was because the sympathetic gan-
glion block raised the thermoregulatory blood flow and re-
duced the nutritive blood flow including oxygen, and so a 
sympathetic  ganglion  block  is  not  indicated  for  eryth-
romelalgia [3]. Yet if other treatments fail to alleviate the 
pain, a sympathetic ganglion block may be tried. The exact 
mechanism of a sympathetic ganglion block in an eryth-
romelalgia patient is not clear but several therories are 
suggested.  First,  vasoconstriction  starts  before  the  re-
active vasodilation that's similar to Raynaud's phenomenon 
occurs [18]. Second, small afferent nerves are attacked by 
the disease and this causes neuropathic pain [19]. Third, 
the platelets are activated and they coagulate, blocking the 
arteries [6]. Sympathetic ganglion block has effect on neu-
ropathic pain and can relieve vasoconstriction and increase 
blood flow, so the pain can be improved. In our patient's 
case, the caudal block did not mitigate the symptoms, so 
we tried a lumbar sympathetic block twice. Her condition 
improved and she has remained so for 6 months of fol-
low-up.
　　In conclusion, many different treatments can be used 
to  manage  the  pain  of  erythromelalgia.  A  sympathetic 
block may be an effective for those cases that are re-
fractory to non-invasive treatment.
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